Viewing Study NCT02235727


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-02-11 @ 11:25 AM
Study NCT ID: NCT02235727
Status: COMPLETED
Last Update Posted: 2017-01-24
First Post: 2014-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of GBR 900 in a Single Ascending Dose Study in Healthy Subjects
Sponsor: Glenmark Pharmaceuticals Ltd. India
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module